Literature DB >> 2554845

Disseminated cytomegalovirus infection presenting with acalculous cholecystitis and acute pancreatitis.

E H Bigio1, A K Haque.   

Abstract

Disseminated cytomegalovirus (CMV) infection occurs predominantly in immunocompromised hosts. Symptomatic CMV cholecystitis and pancreatitis are quite rare, and, to our knowledge, there are no reports of these occurring simultaneously. We describe a patient with a history of chronic myelogenous leukemia (treated with chemotherapy) who presented with recurrent unexplained fevers and an acute abdomen. At surgery, cholecystitis and pancreatitis were found, and a cholecystectomy was performed. The patient developed disseminated intravascular coagulation, eventual sepsis, and multiorgan failure. At autopsy, widespread disseminated CMV infection was found, with CMV-associated foci of acute inflammation and necrosis in the pancreas and in the surgically resected gallbladder. A review of our autopsy files revealed only one renal transplant patient with CMV inclusions and chronic pancreatitis. No pancreatitis was seen in 27 patients with acquired immunodeficiency syndrome. Cytomegalovirus should be considered as a possible cause of pancreatitis and cholecystitis in immunocompromised patients.

Entities:  

Mesh:

Year:  1989        PMID: 2554845

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

1.  Cytomegalovirus infection of the nasopharynx.

Authors:  B W Chan; J K S Woo; C T Liew
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Case report: cytomegalovirus primoinfection may be associated with severe outcome in burns.

Authors:  C Augris; M Benyamina; F Rozenberg; S Gaucher; D Wassermann; C Vinsonneau
Journal:  Ann Burns Fire Disasters       Date:  2007-12-31

Review 3.  Viral-Attributed Acute Pancreatitis: A Systematic Review.

Authors:  C Roberto Simons-Linares; Zaid Imam; Prabhleen Chahal
Journal:  Dig Dis Sci       Date:  2020-08-12       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.